Skip to content

HydroMark CA000408002Recalls & reported problems

Devicor Medical Products, Inc. · HydroMARK Breast Biopsy Site Marker- Non CE · Class 2 · Implant

All models of HydroMark (11)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00841911100195), received between May 16, 2023 and Oct 16, 2025 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Hypersensitivity/Allergic reaction2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 16, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE REPORTER, THE EVENT OCCURRED AFTER THE PROCEDURE AND THE PATIENT HAD AN ALLERGIC REACTION TO A HYDROMARK OPEN-COIL TITANIUM MARKER. THE REPORTER DID NOT HAVE THE PRODUCT CODE OR THE LOT NUMBER OF THE MARKER USED. ON (B)(6) 2025, ABOUT 3 HOURS POST MARKER PLACEMENT, THE PATIENT DEVELOPED HIVES AND FELT HOT. THE PATIENT WENT TO THE EMERGENCY ROOM AND WAS TREATED WITH EPINEPHRINE. THE MARKER WAS SURGICALLY REMOVED TWO DAYS LATER ON (B)(6) 2025. THE PATIENT'S SYMPTOMS ARE RESOLVING. THE PATIENT IS ALLERGIC TO LATEX, ALTHOUGH NO LATEX WAS USED DURING THE BIOPSY. THE BIOPSY DEVICE BEING USED WAS A HOLOGIC BREVERA 9G NEEDLE. THIS WAS A STEREOTACTIC GUIDED BIOPSY. COMPLAINT DEVICE: -4010-04-09-T3 -LOT #F12526208D OR LOT# F12509102D-ACCOUNT DOES NOT KNOW WHICH LOT WAS USED. THE PROCEDURE WAS COMPLETED WITH THESE DEVICES.

    Patient problems: Hypersensitivity/Allergic reaction

    MAUDE report 23310763 ↗
  • InjuryMay 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED BY THE SALES REPRESENTATIVE THAT THE PATIENT HAD AN ALLERGIC REACTION TO THE HYDROGEL (POLYETHYLENE GLYCOL) THAT SURROUNDS THE HYDROMARK TISSUE MARKER. THE HYDROMARK WAS PLACED DURING A STEREO BIOPSY.

    Patient problems: Hypersensitivity/Allergic reaction

    MAUDE report 16941480 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page